Tinavi Medical Technologies Co Ltd (688277) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.019x

Based on the latest financial reports, Tinavi Medical Technologies Co Ltd (688277) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥24.50 Million ≈ $3.59 Million USD) by net assets (CN¥1.29 Billion ≈ $189.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Tinavi Medical Technologies Co Ltd (688277) market capitalisation for the company's overall valuation and market capitalisation.

Tinavi Medical Technologies Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Tinavi Medical Technologies Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Tinavi Medical Technologies Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tinavi Medical Technologies Co Ltd ranked by their cash flow conversion efficiency. Explore how high is Tinavi Medical Technologies Co Ltd's earnings quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund
NYSE:PTA
N/A
Dividend 15 Split Corp
TO:DFN
0.024x
Upbound Group Inc.
NASDAQ:UPBD
0.168x
Huafa Industrial Co Ltd Zhuhai
SHG:600325
0.074x
NB Bancorp, Inc. Common Stock
NASDAQ:NBBK
0.041x
Compagnie des Alpes S.A.
PA:CDA
0.320x
Lihuayi Weiyuan Chemical Co Ltd
SHG:600955
0.007x
Nobia AB
ST:NOBI
-0.026x

Annual Cash Flow Conversion Efficiency for Tinavi Medical Technologies Co Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Tinavi Medical Technologies Co Ltd from 2013 to 2025. View current stock price of Tinavi Medical Technologies Co Ltd for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥3.01 Billion
≈ $439.93 Million
CN¥-51.17 Million
≈ $-7.49 Million
-0.017x +77.92%
2024-12-31 CN¥1.28 Billion
≈ $187.32 Million
CN¥-98.65 Million
≈ $-14.44 Million
-0.077x +44.06%
2023-12-31 CN¥1.24 Billion
≈ $181.09 Million
CN¥-170.50 Million
≈ $-24.95 Million
-0.138x -75.95%
2022-12-31 CN¥1.12 Billion
≈ $163.54 Million
CN¥-87.51 Million
≈ $-12.80 Million
-0.078x -7.51%
2021-12-31 CN¥1.07 Billion
≈ $156.22 Million
CN¥-77.76 Million
≈ $-11.38 Million
-0.073x -29.85%
2020-12-31 CN¥1.03 Billion
≈ $150.22 Million
CN¥-57.58 Million
≈ $-8.43 Million
-0.056x -262.91%
2019-12-31 CN¥596.34 Million
≈ $87.26 Million
CN¥20.53 Million
≈ $3.00 Million
0.034x +46.76%
2018-12-31 CN¥560.61 Million
≈ $82.04 Million
CN¥13.15 Million
≈ $1.92 Million
0.023x -30.62%
2017-12-31 CN¥169.41 Million
≈ $24.79 Million
CN¥5.73 Million
≈ $838.18K
0.034x +114.13%
2016-12-31 CN¥136.62 Million
≈ $19.99 Million
CN¥-32.70 Million
≈ $-4.78 Million
-0.239x -216.74%
2015-12-31 CN¥203.98 Million
≈ $29.85 Million
CN¥41.82 Million
≈ $6.12 Million
0.205x +132.02%
2014-12-31 CN¥52.84 Million
≈ $7.73 Million
CN¥-33.84 Million
≈ $-4.95 Million
-0.640x -460.95%
2013-12-31 CN¥29.60 Million
≈ $4.33 Million
CN¥-3.38 Million
≈ $-494.53K
-0.114x --

About Tinavi Medical Technologies Co Ltd

SHG:688277 China Medical Instruments & Supplies
Market Cap
$998.22 Million
CN¥6.82 Billion CNY
Market Cap Rank
#8963 Global
#2194 in China
Share Price
CN¥14.96
Change (1 day)
+2.05%
52-Week Range
CN¥14.28 - CN¥27.95
All Time High
CN¥141.60
About

Tinavi Medical Technologies Co.,Ltd. engages in the research and development, production, sale, market, service, and clinical application of orthopedic surgery robots and related technologies. The company offers TiRobot II, an orthopedic robotic system to create an operation center; TiRobot, an orthopedic robotic system used in implants in surgery for spine and trauma; 5G remote surgery systems; … Read more